Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter studySwaminathan P. Iyer, Bradley M. Haverkos, Tatyana Feldman et al.|Haematologica|2023Cited by 24
Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center StudySwaminathan P. Iyer, Brad M. Haverkos, Auris Huen et al.|Blood|2021Cited by 15
A Multi-Center, Open Label, Phase I/II Study to Assess the Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell LymphomaSwaminathan P. Iyer, Ajit Nair, Auris Huen et al.|Blood|2020Cited by 1